| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |